SCINAI IMMUNOTHERAPEUTICS LTD. Deferred Tax Assets, Operating Loss Carryforwards
SCINAI IMMUNOTHERAPEUTICS LTD. (SCNI) had Deferred Tax Assets, Operating Loss Carryforwards of $28.14 million as of 2025-12-31, per its 20-F filed 2026-04-01.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsOperatingLossCarryforwards · last filed 2026-04-01
- 2025-12-31: Deferred Tax Assets, Operating Loss Carryforwards $28.14M.
- 2024-12-31: Deferred Tax Assets, Operating Loss Carryforwards $23.38M.
- 2023-12-31: Deferred Tax Assets, Operating Loss Carryforwards $26.11M.
- 2022-12-31: Deferred Tax Assets, Operating Loss Carryforwards $21.68M.
| Period end | Deferred Tax Assets, Operating Loss Carryforwards |
|---|---|
| 2025-12-31 | $28.14M 20-F · filed 2026-04-01 |
| 2024-12-31 | $23.38M 20-F · filed 2026-04-01 |
| 2023-12-31 | $26.11M 20-F · filed 2025-05-07 |
| 2022-12-31 | $21.68M 20-F · filed 2024-05-15 |
| 2021-12-31 | $19.57M 10-K · filed 2023-04-17 |